BSECompany Update5d ago · 10 Oct 2026, 06:25 pm
Solara Active Pharma has informed the Exchange regarding the ESG Rating received from Crisil ESG Rating & Analytics Limited
Solara Active Pharma Sciences Ltd · 541540
✦ AI SummaryESG
Solara Active Pharma Sciences Ltd has received an ESG rating of Crisil ESG 63 under the Strong category from Crisil ESG Ratings & Analytics Limited for Fiscal 2026. The rating is an upgrade from Crisil ESG 56 for the period ended March 31, 2025.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment6/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Solara Active Pharma Sciences Ltd - 541540 - Intimation Of ESG Rating
Attachments (1)
📄pdf
Download →
72587c22-32e5-4a3f-bf43-deff220077ec.pdf
View document text
Corporate Office:
Solara Active Pharma Sciences Limited
TICEL Bio Park, 6th Floor,
Module No. 601, 602, 603, Phase II – CSIR Road,
Taramani, Chennai, Tamil Nadu – 600113.
Tel: +91 44 4344 6700
Fax: +91 44 47406190
E-mail: investors@solara.co.in
Website: www.solara.co.in
Date: October 10, 2026
The BSE Limited The National Stock Exchange of India Limited
Phiroze Jeejeebhoy Towers Exchange Plaza, C-1, Block G, Bandra-Kurla
Dalal Street, Mumbai – 400 001 Complex, Bandra (E), Mumbai – 400 051
Scrip Code: 541540, 890202 Symbol: SOLARA, SOLARAPP1
Dear Sir / Madam,
Subject: Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure
Requirements) Regulations, 2015 – Intimation of ESG Rating.
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements)
Regulations, 2015 read with SEBI Master Circular HO/49/14/14(7)2025-CFD-POD2/I/3762/2026
dated January 30, 2026, we wish to inform you that the Company has received ESG Rating for
Fiscal 2026 (period ended March 31, 2026) from Crisil ESG Ratings & Analytics Limited (‘Crisil
ESG Ratings’), a SEBI registered Category 1 ESG rating provider, vide its email dated October 09,
2026.
The details of the rating are as under:
Type of Rating Environmental, Social and Governance (ESG) rating
Rating received Crisil ESG 63 under Strong category
(upgraded from Crisil ESG 56 for the period ended March 31, 2025)
Please note that the Company has not engaged CRISIL ESG Ratings for the ESG rating. The
aforesaid rating has been assigned independently by CRISIL ESG Ratings based on the disclosures
made by the Company for the financial year 2026 and other publicly available information.
This intimation is also being uploaded on the website of the Company at www.solara.co.in.
We request you to take the above information on your records.
Thanking You,
Yours Faithfully,
For Solara Active Pharma Sciences Limited
Pooja Jaya Kumar
Company Secretary and Compliance Officer
Membership No: A57415
Solara Active Pharma Sciences Limited - CIN: L24230MH2017PLC291636
Registered Office: ‘Cyber One’, Unit No. 902, Plot No. 4 & 6, Sector 30A, Vashi, Navi Mumbai - 400 703 / Tel: +91-22-20870033